Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Adherence to omalizumab: A multicenter "real-world" study.

Campisi R, Crimi C, Intravaia R, Strano S, Noto A, Foschino MP, Valenti G, Viviano V, Pelaia C, Ricciardi L, Scichilone N, Crimi N.

World Allergy Organ J. 2020 Feb 12;13(2):100103. doi: 10.1016/j.waojou.2020.100103. eCollection 2020 Feb.

PMID:
32082464
2.

Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives.

Pelaia C, Vatrella A, Sciacqua A, Terracciano R, Pelaia G.

Expert Rev Respir Med. 2020 Feb 20. doi: 10.1080/17476348.2020.1732821. [Epub ahead of print]

PMID:
32077346
3.

Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.

Sposato B, Camiciottoli G, Bacci E, Scalese M, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Masieri S, Corsico A, Scichilone N, Baglioni S, Murgia N, Folletti I, Bardi G, Grosso A, Cameli P, Latorre M, Musarra A, Bargagli E, Ricci A, Pelaia G, Paggiaro P, Rogliani P.

Pulm Pharmacol Ther. 2020 Jan 21;61:101899. doi: 10.1016/j.pupt.2020.101899. [Epub ahead of print]

PMID:
31972327
4.

Interleukin-5 in the Pathophysiology of Severe Asthma.

Pelaia C, Paoletti G, Puggioni F, Racca F, Pelaia G, Canonica GW, Heffler E.

Front Physiol. 2019 Dec 17;10:1514. doi: 10.3389/fphys.2019.01514. eCollection 2019. Review.

5.

NEW TREATMENTS FOR ASTHMA: FROM THE PATHOGENIC ROLE OF PROSTAGLANDIN D2 TO THE THERAPEUTIC EFFECTS OF FEVIPIPRANT.

Pelaia C, Crimi C, Vatrella A, Busceti MT, Gaudio A, Garofalo E, Bruni A, Terracciano R, Pelaia G.

Pharmacol Res. 2019 Nov 1:104490. doi: 10.1016/j.phrs.2019.104490. [Epub ahead of print] Review.

PMID:
31682916
6.

Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study.

Garofalo E, Bruni A, Pelaia C, Landoni G, Zangrillo A, Antonelli M, Conti G, Biasucci DG, Mercurio G, Cortegiani A, Giarratano A, Vetrugno L, Bove T, Forfori F, Corradi F, Vaschetto R, Cammarota G, Astuto M, Murabito P, Bellini V, Zambon M, Longhini F, Navalesi P, Bignami E.

Ultrasound J. 2019 Oct 3;11(1):21. doi: 10.1186/s13089-019-0137-4.

7.

Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study.

Longhini F, Maugeri J, Andreoni C, Ronco C, Bruni A, Garofalo E, Pelaia C, Cavicchi C, Pintaudi S, Navalesi P.

Ann Intensive Care. 2019 Aug 13;9(1):88. doi: 10.1186/s13613-019-0565-0.

8.

Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.

Pelaia C, Busceti MT, Vatrella A, Rago GF, Crimi C, Terracciano R, Pelaia G.

Pulm Pharmacol Ther. 2019 Oct;58:101830. doi: 10.1016/j.pupt.2019.101830. Epub 2019 Jul 22.

PMID:
31344472
9.

25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine.

Gallelli L, Michniewicz A, Cione E, Squillace A, Colosimo M, Pelaia C, Fazio A, Zampogna S, Peltrone F, Iannacchero R, Sarro G, Working Group GAS, Salerno M, Di Mizio G.

J Clin Med. 2019 Jun 22;8(6). pii: E895. doi: 10.3390/jcm8060895.

10.

Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study.

Terracciano R, Preianò M, Maggisano G, Pelaia C, Savino R.

Molecules. 2019 Jun 22;24(12). pii: E2311. doi: 10.3390/molecules24122311.

11.

Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP.

Garofalo E, Bruni A, Pelaia C, Cammarota G, Murabito P, Biamonte E, Abdalla K, Longhini F, Navalesi P.

Respir Care. 2019 Oct;64(10):1231-1239. doi: 10.4187/respcare.06871. Epub 2019 Jun 4.

PMID:
31164484
12.

Single Inhaler LABA/LAMA for COPD.

Malerba M, Foci V, Patrucco F, Pochetti P, Nardin M, Pelaia C, Radaeli A.

Front Pharmacol. 2019 Apr 25;10:390. doi: 10.3389/fphar.2019.00390. eCollection 2019.

13.

Patient-ventilator asynchrony in adult critically ill patients.

Bruni A, Garofalo E, Pelaia C, Messina A, Cammarota G, Murabito P, Corrado S, Vetrugno L, Longhini F, Navalesi P.

Minerva Anestesiol. 2019 Jun;85(6):676-688. doi: 10.23736/S0375-9393.19.13436-0. Epub 2019 Feb 13.

14.

Rapid Detection and Identification of Antimicrobial Peptide Fingerprints of Nasal Fluid by Mesoporous Silica Particles and MALDI-TOF/TOF Mass Spectrometry: From the Analytical Approach to the Diagnostic Applicability in Precision Medicine.

Preianò M, Maggisano G, Murfuni MS, Villella C, Colica C, Fregola A, Pelaia C, Lombardo N, Pelaia G, Savino R, Terracciano R.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E4005. doi: 10.3390/ijms19124005.

15.

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.

Pelaia C, Calabrese C, Barbuto S, Busceti MT, Preianò M, Gallelli L, Savino R, Vatrella A, Pelaia G.

Pulm Pharmacol Ther. 2019 Feb;54:25-30. doi: 10.1016/j.pupt.2018.11.002. Epub 2018 Nov 7.

PMID:
30414440
16.

Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.

Pelaia C, Calabrese C, Terracciano R, de Blasio F, Vatrella A, Pelaia G.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192. Review.

17.

Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis.

Messina A, Pelaia C, Bruni A, Garofalo E, Bonicolini E, Longhini F, Dellara E, Saderi L, Romagnoli S, Sotgiu G, Cecconi M, Navalesi P.

Anesth Analg. 2018 Dec;127(6):1353-1364. doi: 10.1213/ANE.0000000000003834.

PMID:
30300177
18.

Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study.

Pelaia C, Busceti MT, Solinas S, Terracciano R, Pelaia G.

Pulm Pharmacol Ther. 2018 Dec;53:1-5. doi: 10.1016/j.pupt.2018.09.006. Epub 2018 Sep 11.

PMID:
30217438
19.

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.

Pelaia C, Calabrese C, Vatrella A, Busceti MT, Garofalo E, Lombardo N, Terracciano R, Pelaia G.

Biomed Res Int. 2018 May 10;2018:4839230. doi: 10.1155/2018/4839230. eCollection 2018. Review.

20.

Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation.

Garofalo E, Bruni A, Pelaia C, Liparota L, Lombardo N, Longhini F, Navalesi P.

Expert Rev Respir Med. 2018 Jul;12(7):557-567. doi: 10.1080/17476348.2018.1480941. Epub 2018 May 31. Review.

PMID:
29792537
21.

Maxillary sinus mucocele with orbital complications.

Lombardo N, Ferrise P, Piazzetta GL, Bruzzichessi D, Testa D, Viola P, Pelaia C, Motta G.

Ann Ital Chir. 2018 Apr 9;7. pii: S2239253X18028190.

PMID:
29661986
22.

Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.

Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G.

Drug Des Devel Ther. 2018 Mar 21;12:619-628. doi: 10.2147/DDDT.S155307. eCollection 2018. Review.

23.

An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS.

Preianò M, Maggisano G, Murfuni MS, Villella C, Pelaia C, Montalcini T, Lombardo N, Pelaia G, Savino R, Terracciano R.

Proteomics Clin Appl. 2018 Sep;12(5):e1800005. doi: 10.1002/prca.201800005. Epub 2018 Apr 23.

PMID:
29603653
24.

Mechanical ventilation in brain injured patients: seeing the forest for the trees.

Bruni A, Garofalo E, Pelaia C, Longhini F, Navalesi P.

J Thorac Dis. 2017 Oct;9(10):3483-3487. doi: 10.21037/jtd.2017.08.149. No abstract available.

25.

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.

Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G.

Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017. Review.

26.

Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children.

Pelaia C, Vatrella A, Lombardo N, Terracciano R, Navalesi P, Savino R, Pelaia G.

Expert Opin Biol Ther. 2018 Feb;18(2):197-204. doi: 10.1080/14712598.2018.1402003. Epub 2017 Nov 8. Review.

PMID:
29113525
27.

Dupilumab for the treatment of asthma.

Pelaia C, Vatrella A, Gallelli L, Terracciano R, Navalesi P, Maselli R, Pelaia G.

Expert Opin Biol Ther. 2017 Dec;17(12):1565-1572. doi: 10.1080/14712598.2017.1387245. Epub 2017 Oct 8. Review.

PMID:
28990423
28.

Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.

Vitale C, Maglio A, Pelaia C, Vatrella A.

Expert Opin Pharmacother. 2017 May;18(7):667-676. doi: 10.1080/14656566.2017.1317747. Epub 2017 Apr 20. Review.

PMID:
28387160

Supplemental Content

Loading ...
Support Center